Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015;79(3):470-7.
doi: 10.1253/circj.CJ-15-0064. Epub 2015 Feb 5.

Diastolic dysfunction

Euy-Myoung Jeong  1 , Samuel C Dudley Jr
Affiliations
Review

Diastolic dysfunction

Euy-Myoung Jeong et al. Circ J. 2015.

Abstract

Despite the growing number of patients affected, the understanding of diastolic dysfunction and heart failure with preserved ejection fraction (HFpEF) is still poor. Clinical trials, largely based on successful treatments for systolic heart failure, have been disappointing, suggesting that HFpEF has a different pathology to that of systolic dysfunction. In this review, general concepts, epidemiology, diagnosis, and treatment of diastolic dysfunction are summarized, with an emphasis on new experiments suggesting that oxidative stress plays a crucial role in the pathogenesis of at least some forms of the disease. This observation has lead to potential new diagnostics and therapeutics for diastolic dysfunction and heart failure caused by diastolic dysfunction.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Relationship of diastolic dysfunction to HFpEF and HFrEF. Diastolic heart failure is a subset of HFpEF, diastolic dysfunction can exist in HFrEF, and many patients with diastolic dysfunction are asymptomatic. HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction.
Figure 2
Figure 2
Major risk factors for diastolic dysfunction, which can lead to asymptomatic or symptomatic diastolic dysfunction. HTN, hypertension; LVH, left ventricular hypertrophy.
Figure 3
Figure 3
Selected possible mechanisms of diastolic dysfunction. Hypertension (HTN) and diabetes lead to oxidative modification of proteins including cMyBP-C and a decreased myofilament relaxation rate. Targeted antioxidants appear to prevent or treat oxidant stress-induced diastolic dysfunction in animal models, and circulating modified cMyBP-C may serve as a biomarker of disease. Independent of myocyte biology, increased extracellular matrix may cause abnormal LV relaxation. BH4, tetrahydrobiopterin; cMyBP-C, cardiac myosin binding protein C; CTGF, connective tissue growth factor; MMP, matrix metalloprotease; NOS, nitric oxide synthase; ROS, reactive oxygen species; TIMP, tissue inhibitors of MMP; TGF, transforming growth factor.
See this image and copyright information in PMC

References

    1. Dougherty AH, Naccarelli GV, Gray EL, Hicks CH, Goldstein RA. Congestive heart failure with normal systolic function. Am J Cardiol. 1984;54:778–782. - PubMed
    1. LeWinter MM, Meyer M. Mechanisms of diastolic dysfunction in heart failure with a preserved ejection fraction: If it’s not one thing it’s another. Circ Heart Fail. 2013;6:1112–1115. - PMC - PubMed
    1. Redfi MM, Jacobsen SJ, Burnett JC, Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: Appreciating the scope of the heart failure epidemic. JAMA. 2003;289:194–202. - PubMed
    1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Heart Disease and Stroke Statistics 2010 Update: A report from the American Heart Association. Circulation. 2010;121:e46–e215. - PubMed
    1. Ministry of Health, Labour and Welfare. Summary of vital statistics. [accessed January 18, 2015];2005 http://www.mhlw.go.jp/english/database/db-hw/populate/index.html.

Publication types